CCL2 and Cerebral ischemia: Administration of anti-CD147 inhibited inflammatory cytokine (TNFα, IL-6, IL-1β) and monocyte chemotactic protein-1 (MCP-1, CCL2) expression in the spleen, and this was associated with reduced brain injury in cerebral ischemia (79).